| Name | Title | Contact Details |
|---|
Community Research is a Cincinnati, OH-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
BioHelix is a Beverly, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Hematologics is a Seattle, WA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
TAKE CONTROL OF YOUR HEALTH There is an alternative in managing your health. ANY LAB TEST NOW offers a revolutionary healthcare lab testing experience by providing thousands of standard healthcare lab tests in a professional, convenient and cost-effective manner. No more scheduling a doctor`s appointment, wasting time in the waiting room, or wondering when you`ll find out about your test results. With tests starting at $49, and hundreds of locations across the country, now you can take control of your health. THE DIFFERENCE At ANY LAB TEST NOW, you don`t need insurance, a physician`s referral, or an appointment. You really can take control, affordably and quickly. Most test results available in only 24 - 48 hours.
Natera Inc. is a genetic testing company that specializes in analyzing tiny quantities of DNA for reproductive health. Natera operates a CLIA-certified laboratory in San Carlos, Calif., providing a host of preconception and prenatal genetic testing services. Test offerings include pre-implantation genetic diagnosis to identify chromosomal anomalies or inherited genetic conditions in embryos generated during an IVF cycle; products-of-conception testing following miscarriage to analyze fetal chromosomes and understand the cause of the pregnancy loss; non-invasive prenatal testing to determine paternity; carrier screening to detect whether parents carry genetic variations that may result in disease in the child; and Panorama, a safe, simple test for pregnant women that identifies the most common chromosomal anomalies in a fetus as early as nine weeks of gestation. Natera's PreNATUS clinical trial for non-invasive screening of fetal chromosomal anomalies is funded by the NIH and is being conducted by the leaders in maternal-fetal medicine in the United States. These tests were developed by Natera, a laboratory certified under the Clinical Laboratory Improvement Amendments (CLIA). They have not been cleared or approved by the U.S. Food and Drug Administration (FDA). In August, Natera was selected by the World Economic Forum as a Technology Pioneer for innovations in prenatal care. For more information, visit www.natera.com.